Arrowstreet Capital’s PharMerica Corporation PMC Stock Holding History

Arrowstreet Capital’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-52,870	Closed	-$1.17M	–	1624
2016 Q1	$1.17M	Buy	52,870 +8,714	+20%	+$232K	0.01%	932
2015 Q4	$1.54M	Buy	44,156 +26,356	+148%	+$826K	0.01%	865
2015 Q3	$507K	Buy	+17,800	New	+$598K	﹤0.01%	1093
2014 Q4	–	Sell	-67,093	Closed	-$1.64M	–	1393
2014 Q3	$1.64M	Buy	67,093 +34,045	+103%	+$903K	0.01%	641
2014 Q2	$945K	Buy	+33,048	New	+$919K	﹤0.01%	722

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Arrowstreet Capital's PMC Position: Q2 2016 in Review

Arrowstreet Capital sold out of PharMerica Corporation (PMC) in Q2 2016, closing a stake of 52,870 shares — an estimated $1.17M sold.

Arrowstreet Capital first reported a position in PMC in Q2 2014 and held it in 5 quarters. The position peaked at $1.64M in Q3 2014. 174 funds tracked by Wall St. Rank hold PMC as of Q2 2016.

Arrowstreet Capital reported no remaining PharMerica Corporation position as of Q2 2016 after selling out during the quarter.
Arrowstreet Capital sold 52,870 PharMerica Corporation shares in Q2 2016, an estimated $1.17M.
Arrowstreet Capital first reported a position in PharMerica Corporation in Q2 2014 and held it in 5 quarters.
Arrowstreet Capital's PharMerica Corporation position peaked at $1.64M in Q3 2014.
174 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2016.

Based on Arrowstreet Capital's 13F filing for Q2 2016, filed 15 Aug 2016.